TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $15,511,000 | +27.7% | 2,003,991 | 0.0% | 0.14% | +11.0% |
| Q2 2016 | $12,144,000 | -28.9% | 2,003,991 | 0.0% | 0.13% | -29.4% |
| Q1 2016 | $17,074,000 | -28.6% | 2,003,991 | 0.0% | 0.18% | -9.1% |
| Q4 2015 | $23,908,000 | +18.4% | 2,003,991 | 0.0% | 0.20% | +5.9% |
| Q3 2015 | $20,200,000 | -39.2% | 2,003,991 | 0.0% | 0.19% | -36.0% |
| Q2 2015 | $33,246,000 | +4.7% | 2,003,991 | -2.3% | 0.29% | +10.6% |
| Q1 2015 | $31,739,000 | -2.3% | 2,050,313 | 0.0% | 0.26% | -20.2% |
| Q4 2014 | $32,477,000 | +48.5% | 2,050,313 | 0.0% | 0.33% | +19.9% |
| Q3 2014 | $21,877,000 | +7.8% | 2,050,313 | -5.1% | 0.28% | +10.8% |
| Q2 2014 | $20,291,000 | +36.1% | 2,160,965 | 0.0% | 0.25% | +31.1% |
| Q1 2014 | $14,911,000 | +73.8% | 2,160,965 | -1.8% | 0.19% | +57.0% |
| Q4 2013 | $8,579,000 | +183.7% | 2,199,656 | +266.6% | 0.12% | +181.4% |
| Q3 2013 | $3,024,000 | – | 600,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |